Fortress Biotech, Inc. Payments for Repurchase of Preferred Stock and Preference Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Fortress Biotech, Inc. payments for repurchase of preferred stock and preference stock for the quarter ending 2020-09-30 was $0.00.
- Fortress Biotech, Inc. payments for repurchase of preferred stock and preference stock for the quarter ending 2020-06-30 was $0.00.
- Fortress Biotech, Inc. payments for repurchase of preferred stock and preference stock for the quarter ending 2020-03-31 was $70.00K.
- Fortress Biotech, Inc. payments for repurchase of preferred stock and preference stock for the quarter ending 2019-03-31 was $0.00.
| Period end | Payments for Repurchase of Preferred Stock and Preference Stock 3 month | Payments for Repurchase of Preferred Stock and Preference Stock 12 month |
|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2020-03-31 | $70.00K 10-Q · filed 2020-05-11 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |